Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05110989 · ClinicalTrials.gov registry record
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
A clinical trial of Postoperative Pain, sponsored by AtriCure.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 6
- Study locations
NCT05110989: Recruiting study of Postoperative Pain, sponsored by AtriCure.
NCT05110989 is a study of Postoperative Pain that is actively recruiting participants, run by AtriCure. The registered enrollment target is 5,000 participants, above the 190-participant average among 120 other Postoperative Pain trials with a reported enrollment target (2532% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05110989, a study of Postoperative Pain, is actively recruiting participants, sponsored by AtriCure.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management.
Primary Outcome
Collect pain score to assess the effect of cryoanalgesia effect with a follow up duration of up to 5 years.
Conditions Studied
Interventions
- DEVICE AtriCure Cryo Nerve Block (cryoNB) Device Family
Study Locations (6)
Florida
- AdventHealth - Orlando
Michigan
- Henry Ford Health Rochester Hospital - Rochester
Missouri
- St. Luke's Hospital of Kansas City - Kansas City
New Hampshire
- Elliot Hospital - Manchester
Ohio
- The Christ Hospital - Cincinnati
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2018-06-29 |
| Est. Completion | 2040-01 |
What NCT05110989 shows while recruiting
NCT05110989 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 190-participant average among 120 other Postoperative Pain trials with a reported enrollment target (2532% higher).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which AtriCure Cryo Nerve Block (cryoNB) Device Family is the first listed.
NCT05110989 lists 6 locations in 6 states (Florida, Michigan, Missouri).
Frequently Asked Questions
What is clinical trial NCT05110989 about?
NCT05110989 is a clinical study titled "A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves". This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management.
What is the current status of trial NCT05110989?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2018-06-29. Estimated completion is 2040-01.
What conditions does trial NCT05110989 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT05110989?
The interventions under investigation include: AtriCure Cryo Nerve Block (cryoNB) Device Family (DEVICE).
Who is sponsoring clinical trial NCT05110989?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05110989 being conducted?
This trial has 6 study locations across Florida, Michigan, Missouri, New Hampshire, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05110989's enrollment target sits among peer trials
5,000 1st of 120 higher than 120 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Characterization of Acute Pain
RECRUITING
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI